Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

AUTOBIO DIAGNOSTICS CO., LTD

Autobio Diagnostics Co., Ltd is a clinical diagnostics company specializing in research & development, production, ma... read more Featured Products: More products

Download Mobile App





Autobio Diagnostics Showcases Automated Microbial Identification and ID-AST Solutions at ECCMID 2022

By LabMedica International staff writers
Posted on 25 Apr 2022

Autobio Diagnostics Co. More...

, Ltd. (Zhengzhou, Henan, China) showcased its fully automated microbial identification and antibiotic susceptibility testing (ID-AST) solutions at this year’s ECCMID, the largest international meeting of clinical microbiologists and infectious diseases specialists.

At ECCMID 2022, Autobio demonstrated the AutoMic-I600 automated ID-AST system for quick and accurate microbial identification and ID-AST that supports automatic sample pipetting, incubation and detection. Five different antibiotic cards, including the most comprehensive antibiotic panels, help microbiologists to find out suitable antimicrobial treatment within much shorter time cost. It supports random placement of multiple varieties of board card along with bidirectional intelligent identification and matching of board card and specimen. With two determination methods (colorimetric and turbidimetric), and four wavelength detection, continuous automated interpretation, and AI algorithm model, the AutoMic-I600 ensures scientific and accurate results.

In addition, Autobio highlighted its MALDI-TOF MS (Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry) system for use in microbiological clinical laboratories for the identification of pathogenic bacteria, especially microaerobes, anaerobes, mycobacteria and fungi. Its powerful database includes more than 16,000 strains covering more than 5,000 species and 1000 genera along with a unique filamentous fungi database of more than 1,000 strains covering 450 +species and 70+ genera. Autobio’s MALDI-TOF MS system features a localized and updatable microbial strain database for high identification accuracy. Autobio also presented the AutoMimo system to improve pipetting efficiency and optimize workflow in the lab when conducting experiments with its MALDI TOF microbial identification system. The instrument is also compatible with MALDI TOF of other brands.

Related Links:
Autobio Diagnostics Co., Ltd. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.